Literature DB >> 26419415

Increased resistance rate to ceftazidime among blood culture isolates of ESBL-producing Escherichia coli in a university-affiliated hospital of China.

Xiao-Yan Yuan1, Dong-Ying Yu1,2, Xue-Hong Qu2, Xin-Qiang Xiao2, Bo Bi2, Sheng-Bo Sun1, Ai-Ying Chang1, Qi-bo Zhang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26419415     DOI： 10.1038/ja.2015.100

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  18 in total

1.  Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3.

Authors:  Laurent Poirel; Marek Gniadkowski; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2002-12       Impact factor: 5.790

2.  Predominant characteristics of CTX-M-producing Klebsiella pneumoniae isolates from patients with lower respiratory tract infection in multiple medical centers in China.

Authors:  Shuchang An; Jichao Chen; Zhanwei Wang; Xiaorong Wang; Xixin Yan; Jihong Li; Yusheng Chen; Qi Wang; Xiaoling Xu; Jiabin Li; Jingping Yang; Hui Wang; Zhancheng Gao
Journal:  FEMS Microbiol Lett       Date:  2012-05-28       Impact factor: 2.742

3.  Importance of organisms producing broad-spectrum SHV-group beta-lactamases into the United Kingdom.

Authors:  K P Shannon; A King; I Phillips; M H Nicolas; A Philippon
Journal:  J Antimicrob Chemother       Date:  1990-03       Impact factor: 5.790

Review 4.  New definitions of extended-spectrum β-lactamase conferring worldwide emerging antibiotic resistance.

Authors:  Jung Hun Lee; Il Kwon Bae; Sang Hee Lee
Journal:  Med Res Rev       Date:  2010-06-23       Impact factor: 12.944

5.  Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240-->Gly.

Authors:  R Bonnet; C Dutour; J L Sampaio; C Chanal; D Sirot; R Labia; C De Champs; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

6.  Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.

Authors:  Jesús Rodríguez-Baño; Maria D Navarro; Luisa Romero; Miguel A Muniain; Marina de Cueto; María J Ríos; José R Hernández; Alvaro Pascual
Journal:  Clin Infect Dis       Date:  2006-10-25       Impact factor: 9.079

7.  Ceftazidime-hydrolysing CTX-M-15 extended-spectrum beta-lactamase (ESBL) in Poland.

Authors:  Anna Baraniak; Janusz Fiett; Waleria Hryniewicz; Patrice Nordmann; Marek Gniadkowski
Journal:  J Antimicrob Chemother       Date:  2002-09       Impact factor: 5.790

Review 8.  Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment.

Authors:  Mark E Rupp; Paul D Fey
Journal:  Drugs       Date:  2003       Impact factor: 9.546

9.  The emergence of a novel ceftazidime-resistant CTX-M extended-spectrum beta-lactamase, CTX-M-55, in both community-onset and hospital-acquired infections in Thailand.

Authors:  Pattarachai Kiratisin; Anucha Apisarnthanarak; Piyawan Saifon; Chaitat Laesripa; Rungrueng Kitphati; Linda M Mundy
Journal:  Diagn Microbiol Infect Dis       Date:  2007-04-20       Impact factor: 2.803

10.  Nationwide high prevalence of CTX-M and an increase of CTX-M-55 in Escherichia coli isolated from patients with community-onset infections in Chinese county hospitals.

Authors:  Jing Zhang; Beiwen Zheng; Lina Zhao; Zeqing Wei; Jinru Ji; Lanjuan Li; Yonghong Xiao
Journal:  BMC Infect Dis       Date:  2014-12-03       Impact factor: 3.090
View more
  3 in total

1.  Detection of Plasmid-Mediated Mobile Colistin Resistance Gene (mcr-1) in Enterobacterales Isolates from a University Hospital.

Authors:  Mera Mohammed Galal Anan; Eman Ahmed El-Seidi; Marwa Salah Mostafa; Laila Ahmed Rashed; Doaa Mahdy El-Wakil
Journal:  Infect Drug Resist       Date:  2021-08-11       Impact factor: 4.003

2.  Intestinal carriage of multidrug-resistant gram-negative bacteria in preterm-infants during hospitalization in neonatal intensive care unit (NICU).

Authors:  Polly Soo Xi Yap; Azanna Ahmad Kamar; Chun Wie Chong; Ivan Kok Seng Yap; Kwai Lin Thong; Yao Mun Choo; Mohd Yasim Md Yusof; Cindy Shuan Ju Teh
Journal:  Pathog Glob Health       Date:  2016-09-21       Impact factor: 2.894

3.  A retrospective study on Escherichia coli bacteremia in immunocompromised patients: Microbiological features, clinical characteristics, and risk factors for shock and death.

Authors:  Xiaoyan Tao; Haichen Wang; Changhang Min; Ting Yu; Yi Luo; Jun Li; Yongmei Hu; Qun Yan; Wen' En Liu; Mingxiang Zou
Journal:  J Clin Lab Anal       Date:  2020-04-08       Impact factor: 2.352
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.